中文EN
Level Pressure Sample Comparison Report (with Failure Reasons)
Comparison of L69 / L79 / L84 / L149 against L124, with paid-stage analysis expanded to every paid stage currently visible in the backend. Backend stage data through: 2026-06-14 19:24 Beijing time; report generated: 2026-06-14 19:34 Beijing time.
Executive Summary
- Failure reason changes the explanation, but not the decision: do not copy L124. L69 / L79 / L84 are mostly collision/bacteria failures, with collision shares of 87.5%, 95.7%, and 93.7%, yet revive success is still 96.6%, 94.7%, and 92.9%. L124 is timeout-led: timeout share is 61.6%, revive success is only 79.2%, and player clear rate is 92.7%.
- Collision/bacteria failure is more absorbable by revive; timeout failure usually means the task load is too high. In the 163 qualified stages, collision/bacteria-led stages have a weighted revive success rate of 93.8%, while timeout-led stages are at 88.1%. This is not causal proof, but it matches the focus-level read.
- The paid-stage scope now covers the whole backend, not only L1-L165. There are 216 paid stages, 457 orders, and $2,624.43 revenue. L1-L165 accounts for 114 paid stages and 315 orders; L166+ accounts for 102 paid stages and 142 orders.
- Raising pass rates has a payment tradeoff. Raising attempt clear rate usually reduces direct revive/payment triggers, but raising player clear rate and revive success protects the player base. The healthy balance is not to flatten the whole curve; it is to keep recoverable first-failure pressure on selected pressure levels while avoiding final blockage.
- Failure reason is not a safety switch by itself. L224 is also collision/bacteria-led at 87.1%, but player clear is only 93.2% and revive success is 70.3%. Read failure reason together with attempts per player, revive success, and player clear rate.
Definitions
Target load means how much work the player must finish inside the time limit. It is not just the number of objects; it is the total amount of task pressure the level asks the player to absorb.
Target count / weighted proxy separates the raw number of targets from a rough weighted task proxy. Target count is the visible count. Weighted proxy is a backend-side proxy that gives heavier targets more weight, so it is closer to the real task size than raw count alone.
Task-load pressure is the weighted proxy divided by the time limit. It approximates how much task work the player must complete per second. Higher values tend to increase timeout risk, especially when collision/bacteria interference is also high.
The 10-30 targets or 0.8-1.3 weighted-proxy/sec suggestion is a starting band for new Boss pressure tests, not a universal target. It means: keep the visible target count modest, or keep the time-normalized task load in a moderate range first. If a Boss level needs stronger interference, reduce target load or add time; if target load is high, do not also stack heavy collision/bacteria pressure.
Data Scope
Failure reason comes from stage result events: game_result=4 is timeout, game_result=3 is collision/bacteria, and game_result=2 is quit/other. Revive success is still calculated from result events where resurrection_times>0 and final game_result=1.
Important limitation: we can now compare each stage's final failure mix with its revive outcome, but a successful revived result ends as game_result=1. The current data does not directly tell whether that successful revive was originally triggered by timeout or collision. To answer that per revive attempt, the revive popup / revive accept event needs to carry the triggering failure reason.
163qualified stages for failure-reason analysis
93.8%weighted revive success, collision/bacteria-led
88.1%weighted revive success, timeout-led
216paid stages across the backend
Did Failure Reason Change The Focus-Level Decision?
The decision did not reverse; it became clearer. L69 / L79 / L84 are not simply "hard but harmless". Their pressure is mostly immediate collision/bacteria failure, and revive can still recover the state. L124 is different: timeout dominates, the player has already spent more time, and revive does not easily recover the task load.
| Level | Read | Player clear | Attempt clear | Attempts/player | Revive success | Top failure | Timeout / collision | Payment | Config pressure |
|---|---|---|---|---|---|---|---|---|---|
| L69 Hard node | Strong reference | 99.2% | 79.5% | 1.25 | 96.6% | Collision/bacteria | Timeout 11.8% Collision 87.5% | 2 orders 0.24/100 players | Targets 21 / proxy 119 180s, proxy/sec 0.66 |
| L79 Hard node | Strong reference | 98.9% | 81.5% | 1.21 | 94.7% | Collision/bacteria | Timeout 4.3% Collision 95.7% | 3 orders 0.43/100 players | Targets 117 / proxy 323 200s, proxy/sec 1.61 |
| L84 Hard node | Strong reference | 98.0% | 73.5% | 1.33 | 92.9% | Collision/bacteria | Timeout 6.3% Collision 93.7% | 6 orders 0.94/100 players | Targets 16 / proxy 116 180s, proxy/sec 0.64 |
| L124 Boss node | Counterexample: reduce pressure | 92.7% | 32.3% | 2.87 | 79.2% | Timeout | Timeout 61.6% Collision 38.2% | 9 orders 2.74/100 players | Targets 100 / proxy 377 170s, proxy/sec 2.22 |
| L149 Boss node | Boundary sample | 98.2% | 46.6% | 2.11 | 81.0% | Collision/bacteria | Timeout 50.0% Collision 50.0% | 6 orders 2.67/100 players | Targets 9 / proxy 132 165s, proxy/sec 0.80 |
| L174 Boss node | Later-stage review | 95.2% | 40.7% | 2.34 | 80.7% | Collision/bacteria | Timeout 32.2% Collision 67.8% | 5 orders 2.99/100 players | Targets 37 / proxy 164 155s, proxy/sec 1.06 |
| L209 Hard node | Later-stage review | 100.0% | 49.4% | 2.03 | 78.5% | Collision/bacteria | Timeout 12.1% Collision 86.9% | 5 orders 4.20/100 players | Targets 23 / proxy 139 230s, proxy/sec 0.60 |
| L224 Boss node | Warning sample | 93.2% | 31.0% | 3.01 | 70.3% | Collision/bacteria | Timeout 12.3% Collision 87.1% | 5 orders 4.85/100 players | Targets 63 / proxy 227 190s, proxy/sec 1.19 |
| L269 Hard node | Later-stage review | 100.0% | 59.1% | 1.69 | 81.8% | Timeout | Timeout 53.5% Collision 46.5% | 5 orders 7.35/100 players | Targets 125 / proxy 372 195s, proxy/sec 1.91 |
Failure Reason And Revive Absorption
In the filtered sample, timeout share has a negative relationship with both revive success and player clear. The correlation is not large enough to be a standalone rule, but it is directionally useful: timeout-heavy levels are usually harder for revive to rescue.
| Failure type | Stages | Failure events | Weighted revive | Median revive | Weighted player clear | Median attempt clear | Paid stages | Orders |
|---|---|---|---|---|---|---|---|---|
| Collision/bacteria-led | 101 | 5,847 | 93.8% | 95.0% | 99.2% | 88.1% | 74 | 178 |
| Timeout-led | 31 | 4,865 | 88.1% | 91.3% | 98.5% | 83.1% | 23 | 82 |
| Mixed failure | 31 | 1,711 | 92.0% | 95.5% | 98.9% | 82.6% | 22 | 46 |
| Relationship | Stages | Pearson | Read |
|---|---|---|---|
| Timeout failure share vs Revive success rate | 163 | -0.203 | negative, weak-to-moderate; read as directional, not causal |
| Timeout failure share vs Player clear rate | 163 | -0.213 | negative, weak-to-moderate; read as directional, not causal |
| Timeout failure share vs Orders per 100 challenge players | 126 | -0.034 | negative, weak-to-moderate; read as directional, not causal |
| Collision/bacteria failure share vs Revive success rate | 163 | 0.201 | positive, weak-to-moderate; read as directional, not causal |
| Collision/bacteria failure share vs Player clear rate | 163 | 0.209 | positive, weak-to-moderate; read as directional, not causal |
| Collision/bacteria failure share vs Orders per 100 challenge players | 126 | 0.080 | positive, weak-to-moderate; read as directional, not causal |
Correlation is not a causal claim. It only says that in the current backend sample, timeout-heavy stages usually have weaker revive absorption. Final design decisions still need task load, time limit, collision/bacteria density, and player clear rate.
All Paid Stages
Payment pressure and failure reason should be read separately. High payment intensity does not only come from timeout stages. Many L166+ paid stages are collision/bacteria-led, but a stage is not automatically a repeatable template if player clear rate or revive success is weak.
| Scope | Paid stages | Orders | Revenue | Challenge users | Median orders/100 | Median player clear | Median revive | Collision-led | Timeout-led |
|---|---|---|---|---|---|---|---|---|---|
| L1-L165 mainline | 114 | 315 | $1,897.85 | 139,745 | 0.26 | 99.4% | 95.0% | 58 | 29 |
| L166+ later/extended | 102 | 142 | $726.58 | 6,215 | 2.51 | 100.0% | 100.0% | 56 | 7 |
| Rank basis | Level | Challenge users | Orders | Orders/100 | Player clear | Revive success | Top failure | Timeout / collision |
|---|---|---|---|---|---|---|---|---|
| Raw order top | L11 | 5,096 | 23 | 0.45 | 99.8% | - | Quit/other | 50.0% / 0.0% |
| Raw order top | L31 | 2,358 | 11 | 0.47 | 99.3% | 93.5% | Collision/bacteria | 33.3% / 66.7% |
| Raw order top | L124 | 329 | 9 | 2.74 | 92.7% | 79.2% | Timeout | 61.6% / 38.2% |
| Raw order top | L12 | 4,995 | 8 | 0.16 | 99.1% | 77.8% | Timeout | 72.7% / 0.0% |
| Raw order top | L29 | 2,525 | 7 | 0.28 | 97.3% | 84.9% | Timeout | 69.2% / 29.1% |
| Raw order top | L74 | 794 | 7 | 0.88 | 97.9% | 85.2% | Timeout | 68.4% / 30.8% |
| Raw order top | L48 | 1,350 | 6 | 0.44 | 98.9% | 92.3% | Timeout | 61.9% / 32.7% |
| Raw order top | L14 | 4,416 | 6 | 0.14 | 99.7% | 100.0% | Timeout | 55.0% / 0.0% |
| Raw order top | L99 | 506 | 6 | 1.19 | 96.6% | 85.4% | Timeout | 79.9% / 19.7% |
| Raw order top | L84 | 635 | 6 | 0.94 | 98.0% | 92.9% | Collision/bacteria | 6.3% / 93.7% |
| Raw order top | L149 | 225 | 6 | 2.67 | 98.2% | 81.0% | Collision/bacteria | 50.0% / 50.0% |
| Raw order top | L33 | 2,195 | 6 | 0.27 | 97.9% | 86.7% | Timeout | 71.2% / 27.1% |
| Normalized top | L269 | 68 | 5 | 7.35 | 100.0% | 81.8% | Timeout | 53.5% / 46.5% |
| Normalized top | L368 | 34 | 2 | 5.88 | 100.0% | 100.0% | Collision/bacteria | 0.0% / 100.0% |
| Normalized top | L359 | 37 | 2 | 5.41 | 100.0% | 81.8% | Collision/bacteria | 40.0% / 60.0% |
| Normalized top | L224 | 103 | 5 | 4.85 | 93.2% | 70.3% | Collision/bacteria | 12.3% / 87.1% |
| Normalized top | L209 | 119 | 5 | 4.20 | 100.0% | 78.5% | Collision/bacteria | 12.1% / 86.9% |
| Normalized top | L242 | 78 | 3 | 3.85 | 100.0% | 100.0% | Collision/bacteria | 50.0% / 50.0% |
| Normalized top | L239 | 84 | 3 | 3.57 | 96.4% | 89.7% | Collision/bacteria | 25.9% / 74.1% |
| Normalized top | L234 | 88 | 3 | 3.41 | 98.9% | 87.2% | Collision/bacteria | 15.9% / 84.1% |
| Normalized top | L391 | 30 | 1 | 3.33 | 100.0% | 80.0% | Collision/bacteria | 50.0% / 50.0% |
| Normalized top | L384 | 31 | 1 | 3.23 | 100.0% | 100.0% | Collision/bacteria | 25.0% / 75.0% |
| Normalized top | L229 | 94 | 3 | 3.19 | 98.9% | 90.9% | Collision/bacteria | 20.5% / 77.3% |
| Normalized top | L381 | 32 | 1 | 3.12 | 100.0% | 100.0% | Collision/bacteria | 0.0% / 100.0% |
Will Raising Pass Rates Hurt Payment?
It can, but the right reading is not “lower pass rate earns more”. The clearer pattern in the current sample is: when attempt clear rate rises, direct revive/payment triggers usually fall; when attempts per player and revive usage rise, orders per 100 challenge players rise. But once player clear rate or revive success drops into overload, the extra failure is no longer healthy monetizable pressure. It becomes blockage and retention risk.
The table below uses paid stages with at least 30 challenge players. “Mainline” means L1-L165. These are correlations, not causal proof, but they are useful for tuning direction.
| Relationship | All paid stages | Mainline L1-L165 | How to read it |
|---|---|---|---|
| Attempt clear rate vs orders / 100 challenge players | -0.513 | -0.756 | When first-pass ease goes up, direct revive/payment triggers usually go down. Pushing every pressure level above 95% attempt clear would likely reduce short-term payment opportunities. |
| Attempts per player vs orders / 100 challenge players | +0.527 | +0.830 | Moderate repeat attempts create payment opportunities, as long as players still believe the level is beatable. |
| Revive results per player vs orders / 100 challenge players | +0.515 | +0.702 | The monetizable pattern is recoverable failure, not failure by itself. |
| Player clear rate vs orders / 100 challenge players | -0.147 | -0.484 | Higher paid pressure often comes with lower player clear, but player clear is a guardrail. It should not be intentionally sacrificed for payment. |
| Revive success vs orders / 100 challenge players | -0.260 | -0.317 | As pressure rises, revive recovery tends to weaken. Below 83%-90%, review the level as possible overload. |
Recommended Balance
- Protect player clear rate first, not attempt clear rate. Selected pressure levels can have lower attempt clear to create revive/payment moments; if players ultimately cannot clear, retention and the future payer pool take the hit.
- Healthy paid-pressure band: keep player clear around 98%+ where possible, with 95% as a hard floor; keep revive success preferably above 90%, and review below 83%; attempt clear can sit around 55%-85%, with 70%-85% as a safer mainline band.
- Do not flatten the whole curve to 95%+ attempt clear. In the mainline, low/normal pressure levels have median orders per 100 challenge players of about 0.18-0.28, while light/paid-pressure levels are around 0.91-1.40. Removing all friction would also remove many visible payment triggers.
- Raise passability first on L124-like overloaded levels. If player clear is below 95% or revive success is below 83%, improving clearability may reduce short-term payment intensity, but it is fixing a retention risk.
- Copy the L69 / L79 / L84 / L149 pattern: absorbable failure. These levels are not pressure-free; their failures can be recovered after revive. New Boss pressure tests should follow the same direction: preserve one recoverable failure moment while keeping final clear achievable.
Which Levels To Review
Copy direction: L69 / L79 / L84. These levels are collision/bacteria-led, revive success is high, and player clear remains high. The design pattern to copy is immediate, recoverable pressure, not simply a higher failure count.
Boundary direction: L149. L149 is a mixed-pressure Boss sample. Player clear is still high, but revive success is only 81.0%. It can be used as a boundary test, not as the default curve target.
Clear counterexample: L124. L124 is timeout-led, with low revive success and low player clear. Its issue is not that failure is too invisible; the issue is that task load and time pressure make revive weak.
New late-stage warning: L224. L224 is collision/bacteria-led, but attempts per player are about 3.01, player clear is 93.2%, and revive success is 70.3%. Collision failure can still overload players if the post-revive board state is not recoverable.
Comparison With All in Hole
When comparing with All in Hole, the key difference is not only target count. It is time-normalized load and failure type. O! Hole levels usually have shorter time limits, so the same amount of target work can become much higher per-second pressure.
After adding failure reason, the read is more concrete: pressure can monetize when it comes from collision/bacteria and the post-revive state is recoverable. If pressure comes from timeout, it usually means target load, weighted proxy, or time limit is too tight.
For new Boss pressure tests, start with 10-30 targets or roughly 0.8-1.3 weighted-proxy/sec. Add one guardrail: do not let timeout failures stay above 50%-60%. If timeout becomes the dominant failure reason, reduce task load or add time before relying on revive.
How To Reproduce Strong Levels
- Copy the failure type before copying the numeric difficulty. Strong pressure levels behave like L69 / L79 / L84: most failures are immediate collision/bacteria failures, and revive still lets players recover.
- Do not use L124 as the Boss pressure template. If a Boss level has strong interference, keep target load lower. If target load is high, reduce collision/bacteria concurrency or extend time.
- Watch three red lines. Player clear below 95%, revive success below 83%, and timeout share above 50%-60%. If any two appear together, the level should enter pressure review.
- Validate paid pressure in small batches. L166+ has higher normalized payment intensity but smaller samples. Review L209 / L239 / L234 / L229 as promising paid-pressure samples; treat L224-like stages carefully.
Full Paid Stage Detail
The complete set of 216 paid stages is listed below and sorted by raw order count. Use the normalized orders-per-100 column together with challenge users to avoid over-reading tiny samples.
| Level | Scope | Challenge users | Player clear | Attempt clear | Revive success | Top failure | Timeout | Collision | Orders | Revenue | Orders/100 | Read |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L11 | L1-L165 mainline | 5,096 | 99.8% | 99.1% | - | Quit/other | 50.0% | 0.0% | 23 | $205.77 | 0.45 | Review first |
| L31 | L1-L165 mainline | 2,358 | 99.3% | 93.9% | 93.5% | Collision/bacteria | 33.3% | 66.7% | 11 | $109.89 | 0.47 | Review first |
| L124 | L1-L165 mainline | 329 | 92.7% | 32.3% | 79.2% | Timeout | 61.6% | 38.2% | 9 | $31.91 | 2.74 | Risk review |
| L12 | L1-L165 mainline | 4,995 | 99.1% | 96.7% | 77.8% | Timeout | 72.7% | 0.0% | 8 | $56.92 | 0.16 | Risk review |
| L29 | L1-L165 mainline | 2,525 | 97.3% | 78.8% | 84.9% | Timeout | 69.2% | 29.1% | 7 | $39.93 | 0.28 | Review first |
| L74 | L1-L165 mainline | 794 | 97.9% | 69.0% | 85.2% | Timeout | 68.4% | 30.8% | 7 | $36.93 | 0.88 | Review first |
| L48 | L1-L165 mainline | 1,350 | 98.9% | 87.9% | 92.3% | Timeout | 61.9% | 32.7% | 6 | $42.94 | 0.44 | Review first |
| L14 | L1-L165 mainline | 4,416 | 99.7% | 98.6% | 100.0% | Timeout | 55.0% | 0.0% | 6 | $38.94 | 0.14 | Review first |
| L99 | L1-L165 mainline | 506 | 96.6% | 56.2% | 85.4% | Timeout | 79.9% | 19.7% | 6 | $31.94 | 1.19 | Review first |
| L84 | L1-L165 mainline | 635 | 98.0% | 73.5% | 92.9% | Collision/bacteria | 6.3% | 93.7% | 6 | $27.94 | 0.94 | Review first |
| L149 | L1-L165 mainline | 225 | 98.2% | 46.6% | 81.0% | Collision/bacteria | 50.0% | 50.0% | 6 | $26.94 | 2.67 | Risk review |
| L33 | L1-L165 mainline | 2,195 | 97.9% | 83.6% | 86.7% | Timeout | 71.2% | 27.1% | 6 | $21.94 | 0.27 | Review first |
| L119 | L1-L165 mainline | 363 | 97.5% | 53.5% | 82.8% | Collision/bacteria | 16.3% | 83.7% | 5 | $61.95 | 1.38 | Risk review |
| L81 | L1-L165 mainline | 682 | 99.0% | 87.2% | 95.0% | Collision/bacteria | 17.5% | 77.2% | 5 | $42.95 | 0.73 | Review first |
| L21 | L1-L165 mainline | 3,516 | 98.9% | 92.3% | 94.9% | Timeout | 94.6% | 0.0% | 5 | $34.95 | 0.14 | Review first |
| L89 | L1-L165 mainline | 577 | 97.1% | 63.9% | 91.1% | Collision/bacteria | 39.9% | 60.1% | 5 | $27.95 | 0.87 | Review first |
| L174 | L166+ later/extended | 167 | 95.2% | 40.7% | 80.7% | Collision/bacteria | 32.2% | 67.8% | 5 | $27.95 | 2.99 | Risk review |
| L104 | L1-L165 mainline | 460 | 97.8% | 61.4% | 86.1% | Timeout | 65.9% | 34.1% | 5 | $24.95 | 1.09 | Review first |
| L224 | L166+ later/extended | 103 | 93.2% | 31.0% | 70.3% | Collision/bacteria | 12.3% | 87.1% | 5 | $24.95 | 4.85 | Risk review |
| L209 | L166+ later/extended | 119 | 100.0% | 49.4% | 78.5% | Collision/bacteria | 12.1% | 86.9% | 5 | $18.95 | 4.20 | Risk review |
| L269 | L166+ later/extended | 68 | 100.0% | 59.1% | 81.8% | Timeout | 53.5% | 46.5% | 5 | $15.95 | 7.35 | Risk review |
| L13 | L1-L165 mainline | 4,613 | 98.6% | 93.3% | 100.0% | Timeout | 84.9% | 0.0% | 4 | $37.96 | 0.09 | Review first |
| L22 | L1-L165 mainline | 3,384 | 99.0% | 93.1% | 98.4% | Timeout | 96.8% | 0.0% | 4 | $27.96 | 0.12 | Review first |
| L144 | L1-L165 mainline | 238 | 100.0% | 68.0% | 87.3% | Collision/bacteria | 35.5% | 64.5% | 4 | $21.96 | 1.68 | Review first |
| L42 | L1-L165 mainline | 1,625 | 99.3% | 94.1% | 95.9% | Collision/bacteria | 31.3% | 65.7% | 4 | $19.96 | 0.25 | Review first |
| L82 | L1-L165 mainline | 665 | 99.2% | 91.4% | 95.8% | Timeout | 53.7% | 43.9% | 4 | $17.96 | 0.60 | Review first |
| L47 | L1-L165 mainline | 1,390 | 98.8% | 84.9% | 92.7% | Timeout | 54.9% | 43.4% | 4 | $15.96 | 0.29 | Review first |
| L129 | L1-L165 mainline | 283 | 98.6% | 59.2% | 90.1% | Collision/bacteria | 4.5% | 95.5% | 4 | $13.96 | 1.41 | Review first |
| L54 | L1-L165 mainline | 1,156 | 99.5% | 86.1% | 97.4% | Collision/bacteria | 13.6% | 86.4% | 4 | $11.96 | 0.35 | Review first |
| L71 | L1-L165 mainline | 816 | 99.6% | 92.7% | 96.7% | Collision/bacteria | 0.0% | 100.0% | 3 | $32.97 | 0.37 | Review first |
| L194 | L166+ later/extended | 128 | 99.2% | 75.1% | 94.8% | Collision/bacteria | 27.0% | 70.3% | 3 | $30.97 | 2.34 | Review first |
| L239 | L166+ later/extended | 84 | 96.4% | 54.0% | 89.7% | Collision/bacteria | 25.9% | 74.1% | 3 | $29.97 | 3.57 | Review first |
| L17 | L1-L165 mainline | 4,031 | 98.8% | 90.3% | 93.7% | Timeout | 94.8% | 0.0% | 3 | $23.97 | 0.07 | Review first |
| L27 | L1-L165 mainline | 2,723 | 98.8% | 91.8% | 87.4% | Collision/bacteria | 43.8% | 53.7% | 3 | $23.97 | 0.11 | Review first |
| L242 | L166+ later/extended | 78 | 100.0% | 81.2% | 100.0% | Collision/bacteria | 50.0% | 50.0% | 3 | $22.97 | 3.85 | Review first |
| L83 | L1-L165 mainline | 651 | 99.4% | 89.9% | 94.8% | Collision/bacteria | 21.7% | 76.1% | 3 | $18.97 | 0.46 | Review first |
| L38 | L1-L165 mainline | 1,842 | 99.0% | 88.5% | 89.9% | Collision/bacteria | 23.2% | 76.2% | 3 | $17.97 | 0.16 | Review first |
| L64 | L1-L165 mainline | 930 | 98.7% | 84.1% | 97.3% | Collision/bacteria | 18.9% | 80.2% | 3 | $16.97 | 0.32 | Review first |
| L106 | L1-L165 mainline | 438 | 99.8% | 91.4% | 100.0% | Collision/bacteria | 0.0% | 97.0% | 3 | $16.97 | 0.68 | Review first |
| L234 | L166+ later/extended | 88 | 98.9% | 62.6% | 87.2% | Collision/bacteria | 15.9% | 84.1% | 3 | $16.97 | 3.41 | Review first |
| L23 | L1-L165 mainline | 3,248 | 99.2% | 95.4% | 80.0% | Timeout | 63.2% | 29.8% | 3 | $15.97 | 0.09 | Risk review |
| L53 | L1-L165 mainline | 1,178 | 99.3% | 91.0% | 96.1% | Collision/bacteria | 8.1% | 90.5% | 3 | $15.97 | 0.25 | Review first |
| L229 | L166+ later/extended | 94 | 98.9% | 62.0% | 90.9% | Collision/bacteria | 20.5% | 77.3% | 3 | $14.97 | 3.19 | Review first |
| L37 | L1-L165 mainline | 1,916 | 99.0% | 88.7% | 92.8% | Timeout | 63.3% | 34.0% | 3 | $13.97 | 0.16 | Review first |
| L134 | L1-L165 mainline | 268 | 99.3% | 73.1% | 94.9% | Collision/bacteria | 9.2% | 88.2% | 3 | $13.97 | 1.12 | Review first |
| L34 | L1-L165 mainline | 2,087 | 97.5% | 77.2% | 86.6% | Timeout | 65.2% | 33.0% | 3 | $12.97 | 0.14 | Review first |
| L40 | L1-L165 mainline | 1,702 | 100.0% | 99.1% | - | Quit/other | 33.3% | 0.0% | 3 | $12.97 | 0.18 | Review first |
| L59 | L1-L165 mainline | 1,060 | 98.4% | 82.0% | 95.9% | Collision/bacteria | 1.5% | 98.5% | 3 | $11.97 | 0.28 | Review first |
| L62 | L1-L165 mainline | 966 | 99.8% | 92.7% | 92.0% | Collision/bacteria | 4.2% | 95.8% | 3 | $11.97 | 0.31 | Review first |
| L79 | L1-L165 mainline | 703 | 98.9% | 81.5% | 94.7% | Collision/bacteria | 4.3% | 95.7% | 3 | $8.97 | 0.43 | Review first |
| L32 | L1-L165 mainline | 2,280 | 98.7% | 89.9% | 91.2% | Collision/bacteria | 36.5% | 60.1% | 3 | $7.97 | 0.13 | Review first |
| L49 | L1-L165 mainline | 1,303 | 98.1% | 74.1% | 90.8% | Timeout | 74.9% | 21.9% | 3 | $7.97 | 0.23 | Review first |
| L30 | L1-L165 mainline | 1,937 | 99.9% | 99.8% | - | Quit/other | 0.0% | 0.0% | 3 | $5.97 | 0.15 | Review first |
| L63 | L1-L165 mainline | 952 | 99.3% | 90.5% | 96.1% | Collision/bacteria | 1.6% | 98.4% | 2 | $19.98 | 0.21 | Watch |
| L88 | L1-L165 mainline | 590 | 99.5% | 88.9% | 100.0% | Collision/bacteria | 46.2% | 53.8% | 2 | $18.98 | 0.34 | Watch |
| L25 | L1-L165 mainline | 3,009 | 99.6% | 96.6% | 95.1% | Collision/bacteria | 15.7% | 80.4% | 2 | $17.98 | 0.07 | Watch |
| L16 | L1-L165 mainline | 4,141 | 99.8% | 99.0% | 66.7% | Timeout | 75.0% | 0.0% | 2 | $16.98 | 0.05 | Risk review |
| L101 | L1-L165 mainline | 478 | 99.6% | 89.8% | 91.3% | Timeout | 74.4% | 25.6% | 2 | $14.98 | 0.42 | Watch |
| L138 | L1-L165 mainline | 256 | 100.0% | 92.8% | 95.0% | Collision/bacteria | 26.3% | 73.7% | 2 | $14.98 | 0.78 | Watch |
| L151 | L1-L165 mainline | 214 | 100.0% | 93.4% | 89.5% | Collision/bacteria | 25.0% | 75.0% | 2 | $14.98 | 0.93 | Watch |
| L24 | L1-L165 mainline | 3,137 | 98.2% | 90.0% | 80.3% | Timeout | 54.6% | 41.5% | 2 | $13.98 | 0.06 | Risk review |
| L359 | L166+ later/extended | 37 | 100.0% | 72.5% | 81.8% | Collision/bacteria | 40.0% | 60.0% | 2 | $13.98 | 5.41 | Risk review |
| L28 | L1-L165 mainline | 2,607 | 99.2% | 94.3% | 96.7% | Collision/bacteria | 43.8% | 53.8% | 2 | $11.98 | 0.08 | Watch |
| L39 | L1-L165 mainline | 1,782 | 97.7% | 78.4% | 91.0% | Timeout | 99.1% | 0.0% | 2 | $11.98 | 0.11 | Watch |
| L46 | L1-L165 mainline | 1,411 | 99.7% | 95.2% | 96.6% | Collision/bacteria | 14.6% | 85.4% | 2 | $11.98 | 0.14 | Watch |
| L103 | L1-L165 mainline | 464 | 100.0% | 97.7% | 100.0% | Collision/bacteria | 20.0% | 80.0% | 2 | $11.98 | 0.43 | Watch |
| L139 | L1-L165 mainline | 255 | 99.2% | 79.1% | 88.4% | Collision/bacteria | 32.1% | 67.9% | 2 | $11.98 | 0.78 | Watch |
| L213 | L166+ later/extended | 114 | 100.0% | 94.2% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 2 | $11.98 | 1.75 | Review first |
| L43 | L1-L165 mainline | 1,582 | 99.2% | 93.5% | 95.0% | Collision/bacteria | 22.6% | 74.2% | 2 | $10.98 | 0.13 | Watch |
| L52 | L1-L165 mainline | 1,204 | 99.4% | 87.6% | 95.6% | Collision/bacteria | 25.0% | 72.4% | 2 | $10.98 | 0.17 | Watch |
| L96 | L1-L165 mainline | 521 | 99.8% | 92.2% | 97.6% | Collision/bacteria | 5.7% | 91.4% | 2 | $10.98 | 0.38 | Watch |
| L274 | L166+ later/extended | 67 | 95.5% | 33.2% | 77.4% | Timeout | 53.2% | 46.8% | 2 | $9.98 | 2.99 | Risk review |
| L1329 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 2 | $9.98 | 200.00 | Review first |
| L112 | L1-L165 mainline | 401 | 99.3% | 82.2% | 94.7% | Collision/bacteria | 25.0% | 75.0% | 2 | $8.98 | 0.50 | Watch |
| L44 | L1-L165 mainline | 1,529 | 97.2% | 74.6% | 86.6% | Timeout | 84.7% | 14.5% | 2 | $7.98 | 0.13 | Watch |
| L56 | L1-L165 mainline | 1,123 | 99.6% | 95.9% | 98.8% | Collision/bacteria | 11.1% | 88.9% | 2 | $7.98 | 0.18 | Watch |
| L179 | L166+ later/extended | 149 | 97.3% | 58.0% | 93.0% | Collision/bacteria | 22.4% | 77.6% | 2 | $7.98 | 1.34 | Review first |
| L58 | L1-L165 mainline | 1,082 | 98.7% | 90.8% | 96.5% | Collision/bacteria | 11.8% | 86.8% | 2 | $6.98 | 0.18 | Watch |
| L113 | L1-L165 mainline | 394 | 99.5% | 95.8% | 100.0% | Collision/bacteria | 23.1% | 76.9% | 2 | $6.98 | 0.51 | Watch |
| L141 | L1-L165 mainline | 249 | 100.0% | 92.2% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 2 | $6.98 | 0.80 | Watch |
| L80 | L1-L165 mainline | 687 | 100.0% | 99.6% | - | Quit/other | 0.0% | 0.0% | 2 | $5.98 | 0.29 | Watch |
| L91 | L1-L165 mainline | 551 | 99.6% | 94.3% | 96.6% | Collision/bacteria | 0.0% | 100.0% | 2 | $5.98 | 0.36 | Watch |
| L122 | L1-L165 mainline | 342 | 99.4% | 88.5% | 97.9% | Collision/bacteria | 6.1% | 93.9% | 2 | $5.98 | 0.58 | Watch |
| L178 | L166+ later/extended | 150 | 100.0% | 96.8% | 75.0% | Collision/bacteria | 0.0% | 100.0% | 2 | $5.98 | 1.33 | Risk review |
| L226 | L166+ later/extended | 95 | 100.0% | 94.1% | 100.0% | Collision/bacteria | 16.7% | 83.3% | 2 | $5.98 | 2.11 | Review first |
| L238 | L166+ later/extended | 84 | 100.0% | 90.3% | 100.0% | Collision/bacteria | 33.3% | 66.7% | 2 | $5.98 | 2.38 | Review first |
| L61 | L1-L165 mainline | 989 | 99.4% | 93.5% | 99.2% | Collision/bacteria | 2.4% | 97.6% | 2 | $4.98 | 0.20 | Watch |
| L35 | L1-L165 mainline | 1,985 | 100.0% | 99.3% | 100.0% | Timeout | 80.0% | 0.0% | 2 | $3.98 | 0.10 | Watch |
| L164 | L1-L165 mainline | 186 | 98.9% | 75.7% | 96.0% | Collision/bacteria | 8.5% | 91.5% | 2 | $3.98 | 1.08 | Review first |
| L219 | L166+ later/extended | 109 | 98.2% | 54.3% | 87.0% | Collision/bacteria | 20.3% | 79.7% | 2 | $3.98 | 1.83 | Review first |
| L368 | L166+ later/extended | 34 | 100.0% | 97.1% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 2 | $3.98 | 5.88 | Review first |
| L545 | L166+ later/extended | 8 | 100.0% | 100.0% | - | - | - | - | 2 | $3.98 | 25.00 | Review first |
| L1164 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 2 | $3.98 | 200.00 | Review first |
| L109 | L1-L165 mainline | 418 | 99.5% | 75.9% | 95.8% | Collision/bacteria | 5.0% | 94.1% | 2 | $2.98 | 0.48 | Watch |
| L169 | L166+ later/extended | 180 | 96.1% | 52.9% | 87.3% | Timeout | 50.0% | 49.2% | 2 | $2.98 | 1.11 | Review first |
| L494 | L166+ later/extended | 12 | 100.0% | 63.2% | 80.0% | Collision/bacteria | 16.7% | 83.3% | 2 | $2.98 | 16.67 | Risk review |
| L69 | L1-L165 mainline | 850 | 99.2% | 79.5% | 96.6% | Collision/bacteria | 11.8% | 87.5% | 2 | $1.98 | 0.24 | Watch |
| L127 | L1-L165 mainline | 291 | 99.7% | 83.1% | 88.0% | Timeout | 67.3% | 32.7% | 1 | $14.99 | 0.34 | Watch |
| L136 | L1-L165 mainline | 264 | 97.3% | 61.2% | 86.8% | Timeout | 71.3% | 26.2% | 1 | $14.99 | 0.38 | Watch |
| L162 | L1-L165 mainline | 193 | 99.0% | 94.1% | 94.1% | Collision/bacteria | 25.0% | 62.5% | 1 | $14.99 | 0.52 | Watch |
| L291 | L166+ later/extended | 56 | 100.0% | 93.3% | 100.0% | Timeout | 75.0% | 25.0% | 1 | $14.99 | 1.79 | Review first |
| L391 | L166+ later/extended | 30 | 100.0% | 83.3% | 80.0% | Collision/bacteria | 50.0% | 50.0% | 1 | $14.99 | 3.33 | Risk review |
| L464 | L166+ later/extended | 18 | 94.4% | 58.6% | 81.8% | Collision/bacteria | 0.0% | 100.0% | 1 | $14.99 | 5.56 | Risk review |
| L724 | L166+ later/extended | 3 | 100.0% | 60.0% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $14.99 | 33.33 | Review first |
| L759 | L166+ later/extended | 3 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $14.99 | 33.33 | Review first |
| L1102 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 1 | $14.99 | 100.00 | Review first |
| L18 | L1-L165 mainline | 3,888 | 99.2% | 96.5% | 92.3% | Timeout | 90.2% | 0.0% | 1 | $9.99 | 0.03 | Watch |
| L20 | L1-L165 mainline | 3,626 | 99.9% | 99.0% | - | Quit/other | 50.0% | 0.0% | 1 | $9.99 | 0.03 | Watch |
| L66 | L1-L165 mainline | 885 | 100.0% | 99.8% | - | - | - | - | 1 | $9.99 | 0.11 | Watch |
| L75 | L1-L165 mainline | 755 | 99.9% | 99.2% | - | Quit/other | 0.0% | 0.0% | 1 | $9.99 | 0.13 | Watch |
| L85 | L1-L165 mainline | 611 | 99.8% | 97.8% | 100.0% | Timeout | 88.9% | 0.0% | 1 | $9.99 | 0.16 | Watch |
| L86 | L1-L165 mainline | 604 | 99.5% | 94.2% | 98.1% | Collision/bacteria | 4.8% | 90.5% | 1 | $9.99 | 0.17 | Watch |
| L92 | L1-L165 mainline | 542 | 99.6% | 90.0% | 97.2% | Collision/bacteria | 2.3% | 97.7% | 1 | $9.99 | 0.18 | Watch |
| L100 | L1-L165 mainline | 482 | 100.0% | 99.4% | - | Quit/other | 0.0% | 0.0% | 1 | $9.99 | 0.21 | Watch |
| L108 | L1-L165 mainline | 424 | 99.5% | 84.6% | 94.7% | Collision/bacteria | 13.3% | 86.7% | 1 | $9.99 | 0.24 | Watch |
| L115 | L1-L165 mainline | 381 | 100.0% | 99.2% | - | Quit/other | 0.0% | 0.0% | 1 | $9.99 | 0.26 | Watch |
| L128 | L1-L165 mainline | 287 | 100.0% | 85.9% | 97.3% | Collision/bacteria | 48.6% | 51.4% | 1 | $9.99 | 0.35 | Watch |
| L140 | L1-L165 mainline | 251 | 100.0% | 98.0% | - | Timeout | 100.0% | 0.0% | 1 | $9.99 | 0.40 | Watch |
| L146 | L1-L165 mainline | 232 | 99.6% | 94.7% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $9.99 | 0.43 | Watch |
| L150 | L1-L165 mainline | 217 | 99.5% | 98.6% | - | Timeout | 100.0% | 0.0% | 1 | $9.99 | 0.46 | Watch |
| L177 | L166+ later/extended | 151 | 99.3% | 93.2% | 100.0% | Collision/bacteria | 40.0% | 60.0% | 1 | $9.99 | 0.66 | Watch |
| L181 | L166+ later/extended | 142 | 100.0% | 95.3% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $9.99 | 0.70 | Watch |
| L186 | L166+ later/extended | 136 | 100.0% | 97.1% | 100.0% | Collision/bacteria | 0.0% | 66.7% | 1 | $9.99 | 0.74 | Watch |
| L199 | L166+ later/extended | 125 | 99.2% | 83.2% | 90.0% | Timeout | 66.7% | 33.3% | 1 | $9.99 | 0.80 | Watch |
| L200 | L166+ later/extended | 124 | 100.0% | 100.0% | - | - | - | - | 1 | $9.99 | 0.81 | Watch |
| L223 | L166+ later/extended | 104 | 100.0% | 81.9% | 77.8% | Collision/bacteria | 27.3% | 72.7% | 1 | $9.99 | 0.96 | Risk review |
| L243 | L166+ later/extended | 78 | 100.0% | 92.9% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $9.99 | 1.28 | Review first |
| L247 | L166+ later/extended | 76 | 100.0% | 88.4% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $9.99 | 1.32 | Review first |
| L272 | L166+ later/extended | 68 | 100.0% | 72.3% | 100.0% | Timeout | 60.9% | 39.1% | 1 | $9.99 | 1.47 | Review first |
| L299 | L166+ later/extended | 54 | 96.3% | 45.2% | 80.0% | Collision/bacteria | 49.0% | 49.0% | 1 | $9.99 | 1.85 | Risk review |
| L384 | L166+ later/extended | 31 | 100.0% | 83.8% | 100.0% | Collision/bacteria | 25.0% | 75.0% | 1 | $9.99 | 3.23 | Review first |
| L709 | L166+ later/extended | 3 | 100.0% | 16.7% | 50.0% | Timeout | 100.0% | 0.0% | 1 | $9.99 | 33.33 | Risk review |
| L117 | L1-L165 mainline | 374 | 99.5% | 89.0% | 94.8% | Collision/bacteria | 11.1% | 88.9% | 1 | $7.99 | 0.27 | Watch |
| L248 | L166+ later/extended | 75 | 100.0% | 89.3% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $7.99 | 1.33 | Review first |
| L257 | L166+ later/extended | 73 | 100.0% | 97.3% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $7.99 | 1.37 | Review first |
| L292 | L166+ later/extended | 56 | 100.0% | 94.9% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $7.99 | 1.79 | Review first |
| L659 | L166+ later/extended | 3 | 100.0% | 75.0% | 0.0% | Timeout | 100.0% | 0.0% | 1 | $7.99 | 33.33 | Risk review |
| L696 | L166+ later/extended | 3 | 100.0% | 100.0% | - | - | - | - | 1 | $7.99 | 33.33 | Review first |
| L1052 | L166+ later/extended | 1 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $7.99 | 100.00 | Review first |
| L1149 | L166+ later/extended | 1 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $7.99 | 100.00 | Review first |
| L563 | L166+ later/extended | 7 | 100.0% | 100.0% | - | - | - | - | 1 | $6.99 | 14.29 | Review first |
| L1173 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 1 | $6.99 | 100.00 | Review first |
| L76 | L1-L165 mainline | 742 | 99.5% | 94.0% | 94.3% | Collision/bacteria | 3.4% | 93.1% | 1 | $4.99 | 0.13 | Watch |
| L116 | L1-L165 mainline | 381 | 99.2% | 84.2% | 97.1% | Collision/bacteria | 28.6% | 71.4% | 1 | $4.99 | 0.26 | Watch |
| L135 | L1-L165 mainline | 264 | 100.0% | 99.6% | - | Quit/other | 0.0% | 0.0% | 1 | $4.99 | 0.38 | Watch |
| L167 | L166+ later/extended | 181 | 100.0% | 93.3% | 100.0% | Collision/bacteria | 45.5% | 54.5% | 1 | $4.99 | 0.55 | Watch |
| L203 | L166+ later/extended | 123 | 99.2% | 90.4% | 100.0% | Collision/bacteria | 41.7% | 58.3% | 1 | $4.99 | 0.81 | Watch |
| L232 | L166+ later/extended | 90 | 100.0% | 90.9% | 100.0% | Collision/bacteria | 20.0% | 80.0% | 1 | $4.99 | 1.11 | Review first |
| L246 | L166+ later/extended | 76 | 100.0% | 95.0% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $4.99 | 1.32 | Review first |
| L282 | L166+ later/extended | 59 | 100.0% | 88.1% | 100.0% | Collision/bacteria | 14.3% | 85.7% | 1 | $4.99 | 1.69 | Review first |
| L305 | L166+ later/extended | 47 | 100.0% | 100.0% | - | - | - | - | 1 | $4.99 | 2.13 | Review first |
| L373 | L166+ later/extended | 33 | 100.0% | 82.5% | 100.0% | Collision/bacteria | 40.0% | 60.0% | 1 | $4.99 | 3.03 | Review first |
| L412 | L166+ later/extended | 25 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $4.99 | 4.00 | Review first |
| L416 | L166+ later/extended | 25 | 100.0% | 96.2% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $4.99 | 4.00 | Review first |
| L470 | L166+ later/extended | 15 | 100.0% | 100.0% | - | - | - | - | 1 | $4.99 | 6.67 | Review first |
| L639 | L166+ later/extended | 4 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $4.99 | 25.00 | Review first |
| L754 | L166+ later/extended | 3 | 100.0% | 37.5% | 0.0% | Timeout | 80.0% | 20.0% | 1 | $4.99 | 33.33 | Risk review |
| L927 | L166+ later/extended | 2 | 100.0% | 100.0% | - | - | - | - | 1 | $4.99 | 50.00 | Review first |
| L1047 | L166+ later/extended | 1 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $4.99 | 100.00 | Review first |
| L1240 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 1 | $4.99 | 100.00 | Review first |
| L26 | L1-L165 mainline | 2,837 | 99.1% | 91.9% | 84.2% | Collision/bacteria | 18.4% | 77.2% | 1 | $3.99 | 0.04 | Watch |
| L36 | L1-L165 mainline | 1,968 | 99.3% | 93.6% | 96.1% | Collision/bacteria | 14.5% | 82.9% | 1 | $3.99 | 0.05 | Watch |
| L55 | L1-L165 mainline | 1,136 | 99.9% | 99.5% | 100.0% | - | - | - | 1 | $3.99 | 0.09 | Watch |
| L57 | L1-L165 mainline | 1,107 | 99.2% | 90.3% | 95.7% | Collision/bacteria | 0.0% | 100.0% | 1 | $3.99 | 0.09 | Watch |
| L87 | L1-L165 mainline | 596 | 99.5% | 89.0% | 93.3% | Timeout | 52.9% | 47.1% | 1 | $3.99 | 0.17 | Watch |
| L93 | L1-L165 mainline | 535 | 99.6% | 89.4% | 95.5% | Collision/bacteria | 0.0% | 100.0% | 1 | $3.99 | 0.19 | Watch |
| L97 | L1-L165 mainline | 514 | 99.6% | 95.9% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $3.99 | 0.19 | Watch |
| L102 | L1-L165 mainline | 472 | 99.8% | 88.0% | 100.0% | Collision/bacteria | 34.3% | 65.7% | 1 | $3.99 | 0.21 | Watch |
| L110 | L1-L165 mainline | 412 | 100.0% | 99.3% | - | Timeout | 100.0% | 0.0% | 1 | $3.99 | 0.24 | Watch |
| L154 | L1-L165 mainline | 209 | 99.0% | 66.1% | 88.5% | Collision/bacteria | 26.8% | 72.0% | 1 | $3.99 | 0.48 | Watch |
| L165 | L1-L165 mainline | 184 | 100.0% | 100.0% | - | - | - | - | 1 | $3.99 | 0.54 | Watch |
| L218 | L166+ later/extended | 110 | 99.1% | 82.6% | 100.0% | Timeout | 53.3% | 46.7% | 1 | $3.99 | 0.91 | Watch |
| L369 | L166+ later/extended | 34 | 100.0% | 72.3% | 88.9% | Timeout | 53.8% | 46.2% | 1 | $3.99 | 2.94 | Review first |
| L68 | L1-L165 mainline | 869 | 99.1% | 92.8% | 96.8% | Collision/bacteria | 0.0% | 97.1% | 1 | $2.99 | 0.12 | Watch |
| L285 | L166+ later/extended | 58 | 100.0% | 100.0% | - | - | - | - | 1 | $2.99 | 1.72 | Review first |
| L381 | L166+ later/extended | 32 | 100.0% | 97.0% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $2.99 | 3.12 | Review first |
| L41 | L1-L165 mainline | 1,675 | 99.2% | 92.2% | 95.5% | Timeout | 51.6% | 45.2% | 1 | $1.99 | 0.06 | Watch |
| L114 | L1-L165 mainline | 389 | 98.7% | 82.6% | 97.9% | Collision/bacteria | 43.8% | 54.2% | 1 | $1.99 | 0.26 | Watch |
| L133 | L1-L165 mainline | 270 | 99.6% | 93.7% | 100.0% | Collision/bacteria | 14.3% | 85.7% | 1 | $1.99 | 0.37 | Watch |
| L145 | L1-L165 mainline | 235 | 100.0% | 100.0% | - | - | - | - | 1 | $1.99 | 0.43 | Watch |
| L204 | L166+ later/extended | 121 | 99.2% | 63.5% | 85.2% | Collision/bacteria | 36.1% | 63.9% | 1 | $1.99 | 0.83 | Watch |
| L205 | L166+ later/extended | 120 | 100.0% | 98.4% | - | - | - | - | 1 | $1.99 | 0.83 | Watch |
| L212 | L166+ later/extended | 115 | 99.1% | 92.7% | 100.0% | Collision/bacteria | 42.9% | 57.1% | 1 | $1.99 | 0.87 | Watch |
| L214 | L166+ later/extended | 113 | 99.1% | 64.0% | 87.9% | Collision/bacteria | 15.6% | 82.2% | 1 | $1.99 | 0.88 | Watch |
| L217 | L166+ later/extended | 110 | 100.0% | 90.9% | 100.0% | Collision/bacteria | 0.0% | 87.5% | 1 | $1.99 | 0.91 | Watch |
| L222 | L166+ later/extended | 105 | 100.0% | 80.2% | 100.0% | Collision/bacteria | 47.6% | 52.4% | 1 | $1.99 | 0.95 | Watch |
| L228 | L166+ later/extended | 94 | 100.0% | 93.1% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 1.06 | Review first |
| L237 | L166+ later/extended | 85 | 100.0% | 97.7% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 1.18 | Review first |
| L241 | L166+ later/extended | 78 | 100.0% | 86.7% | 100.0% | Timeout | 60.0% | 30.0% | 1 | $1.99 | 1.28 | Review first |
| L258 | L166+ later/extended | 72 | 98.6% | 75.5% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 1.39 | Review first |
| L264 | L166+ later/extended | 68 | 100.0% | 53.5% | 88.9% | Collision/bacteria | 31.4% | 68.6% | 1 | $1.99 | 1.47 | Review first |
| L289 | L166+ later/extended | 58 | 100.0% | 78.4% | 100.0% | Collision/bacteria | 27.3% | 72.7% | 1 | $1.99 | 1.72 | Review first |
| L309 | L166+ later/extended | 47 | 100.0% | 66.2% | 100.0% | Collision/bacteria | 37.5% | 62.5% | 1 | $1.99 | 2.13 | Review first |
| L319 | L166+ later/extended | 46 | 97.8% | 84.9% | 95.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 2.17 | Review first |
| L325 | L166+ later/extended | 44 | 100.0% | 100.0% | - | - | - | - | 1 | $1.99 | 2.27 | Review first |
| L329 | L166+ later/extended | 44 | 97.7% | 64.2% | 100.0% | Collision/bacteria | 9.1% | 90.9% | 1 | $1.99 | 2.27 | Review first |
| L334 | L166+ later/extended | 42 | 100.0% | 48.8% | 76.9% | Collision/bacteria | 40.0% | 60.0% | 1 | $1.99 | 2.38 | Risk review |
| L349 | L166+ later/extended | 38 | 100.0% | 43.7% | 70.0% | Collision/bacteria | 40.0% | 57.5% | 1 | $1.99 | 2.63 | Risk review |
| L404 | L166+ later/extended | 27 | 100.0% | 50.0% | 91.7% | Collision/bacteria | 14.3% | 85.7% | 1 | $1.99 | 3.70 | Review first |
| L409 | L166+ later/extended | 27 | 96.3% | 66.7% | 86.7% | Collision/bacteria | 18.2% | 81.8% | 1 | $1.99 | 3.70 | Review first |
| L474 | L166+ later/extended | 15 | 93.3% | 50.0% | 88.9% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 6.67 | Risk review |
| L574 | L166+ later/extended | 7 | 100.0% | 63.6% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 14.29 | Review first |
| L634 | L166+ later/extended | 4 | 100.0% | 66.7% | 100.0% | - | - | - | 1 | $1.99 | 25.00 | Review first |
| L637 | L166+ later/extended | 4 | 100.0% | 80.0% | - | Collision/bacteria | 0.0% | 100.0% | 1 | $1.99 | 25.00 | Review first |
| L679 | L166+ later/extended | 3 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $1.99 | 33.33 | Review first |
| L892 | L166+ later/extended | 2 | 100.0% | 100.0% | - | - | - | - | 1 | $1.99 | 50.00 | Review first |
| L967 | L166+ later/extended | 1 | 100.0% | 100.0% | 100.0% | - | - | - | 1 | $1.99 | 100.00 | Review first |
| L1295 | L166+ later/extended | 1 | 100.0% | 100.0% | - | - | - | - | 1 | $1.99 | 100.00 | Review first |
| L45 | L1-L165 mainline | 1,442 | 99.9% | 99.4% | - | Timeout | 100.0% | 0.0% | 1 | $0.99 | 0.07 | Watch |
| L65 | L1-L165 mainline | 899 | 100.0% | 99.7% | - | - | - | - | 1 | $0.99 | 0.11 | Watch |
| L90 | L1-L165 mainline | 458 | 99.8% | 99.6% | - | Quit/other | 0.0% | 0.0% | 1 | $0.99 | 0.22 | Watch |
| L192 | L166+ later/extended | 129 | 100.0% | 97.0% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $0.99 | 0.78 | Watch |
| L208 | L166+ later/extended | 119 | 100.0% | 93.7% | 100.0% | Collision/bacteria | 33.3% | 66.7% | 1 | $0.99 | 0.84 | Watch |
| L271 | L166+ later/extended | 68 | 100.0% | 97.1% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $0.99 | 1.47 | Review first |
| L284 | L166+ later/extended | 59 | 98.3% | 65.9% | 95.8% | Collision/bacteria | 0.0% | 100.0% | 1 | $0.99 | 1.69 | Review first |
| L361 | L166+ later/extended | 37 | 100.0% | 94.9% | 100.0% | Collision/bacteria | 0.0% | 100.0% | 1 | $0.99 | 2.70 | Review first |
Data To Add Next
In result data, add fail duration, remaining target count, whether revive was accepted, and revive type. These fields would let us separate "revive after timeout" from "revive after collision/bacteria" at the attempt level, instead of only reading the relationship at stage level.
Source: backend aggregate data from events-france-hole; stage event window 2026-05-23 09:56 UTC to 2026-06-14 11:24 UTC. Local source tables are kept in /Users/dingzhuqi/Documents/M_Analytics/outputs/level_comparison_20260614.